文献速递湿疹皮炎与荨麻疹

局部外用糖皮质激素戒断是线粒体NAD+过量的可干预靶点

Topical Steroid Withdrawal Is a Targetable Excess of Mitochondrial NAD.
PubMed 文献 · J Invest Dermatol · 2025-03-14

这项多模式初步研究纳入符合局部外用糖皮质激素戒断(TSW)诊断特征的16例患者,并对照特应性皮炎患者(n=10)和健康对照(n=11)。临床评估建立了区分TSW与特应性皮炎的客观诊断标准,代谢组学和转录组学提示神经炎症通路与复合体I介导的NAD+氧化相关。细胞和小鼠模型显示NAD+代谢具有促炎性且受糖皮质激素调控,复合体I阻断可减轻糖皮质激素对特定细胞的代谢效应,并据此开展开放标签试验使用二甲双胍和小檗碱。

要点

  • 临床评估建立了区分TSW与特应性皮炎的客观诊断标准。
  • 皮肤活检代谢组学和转录组学提示神经炎症通路与复合体I介导的NAD+氧化相关。
  • 开放标签试验使用复合体I抑制剂二甲双胍和小檗碱取得成功。

核心结论

  • TSW是线粒体NAD+过量的可干预靶点,复合体I抑制干预在开放标签试验中成功。

研究设计与样本

  • 多模式初步研究纳入16例符合TSW诊断特征的患者,对照特应性皮炎患者10例和健康对照11例。

主要发现

  • 临床评估建立了区分TSW与特应性皮炎的客观诊断标准。
  • 皮肤活检代谢组学和转录组学提示神经炎症通路与复合体I介导的NAD+氧化相关。
  • 细胞和小鼠模型显示NAD+代谢具有促炎性且受糖皮质激素调控。
  • 功能实验显示糖皮质激素对唯一与TSW病理分布和持续时间一致的细胞类型的代谢效应可被复合体I阻断减轻。

临床怎么用

  • 复合体I抑制干预(二甲双胍和小檗碱)在开放标签试验中成功,但需进一步验证。

局限性

  • 本研究为初步研究,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Topical steroid withdrawal (TSW) is a controversial diagnosis advocated by patients but often confused for atopic dermatitis. We conducted a multimodal pilot study of 16 patients fitting the TSW diagnostic profile, contrasting them against patients with atopic dermatitis (n = 10) and healthy controls (n = 11). Our clinical evaluations established objective diagnostic criteria that distinguish TSW from atopic dermatitis, metabolomics and transcriptomics of skin biopsies suggested that neuroinflammatory pathways are associated with complex I-mediated oxidation of NAD+, cellular and mouse models demonstrated that NAD+ metabolism was proinflammatory and glucocorticoid responsive, whereas functional assays demonstrated that the metabolic effects of glucocorticoids on the only cell type that aligns with the distribution and duration of TSW pathology could be mitigated by complex I blockade. These results informed a successful open-label trial using complex I-inhibiting interventions: metformin and berberine. Although this work represents a pilot study, to our knowledge, this work offers previously unreported mechanistic insights into TSW.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Shobnam N, Ratley G, Saksena S, et al. Topical Steroid Withdrawal Is a Targetable Excess of Mitochondrial NAD. J Invest Dermatol. 2025. PMID: 40088241. doi:10.1016/j.jid.2024.11.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。